{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:17:11Z","timestamp":1792808231639,"version":"4.5.0"},"reference-count":18,"publisher":"Bentham Science Publishers Ltd.","issue":"13","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2021,3,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The interaction between cerebral vessel disease (CVD) pathology and Alzheimer\u2019s\ndisease (AD) pathology in the development of dementia is controversial. We examined the\nassociation of cerebral vascular neuropathology and cerebrovascular risk factors with the mild stage of\nAlzheimer's dementia and cognitive function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This cross-sectional study included men and women aged 60 years or over who had yearly\nclinical assessments and had agreed to brain autopsy at the time of death, and who contributed to data\nstored at the National Alzheimer's Coordinating Center (NACC) in the USA. Cognitively normal and\nimpaired subjects with presumptive aetiology of AD, including mild cognitive impairment (ADMCI)\nand dementia (Alzheimer\u2019s dementia), and with complete neuropathological data, were included in our\nanalyses. We used neuropsychological data proximate to death to create summary measures of global\ncognition and cognitive domains. Systematic neuropathological assessments documenting the severity\nof cerebral vascular pathology were included. Logistic and linear regression analyses corrected for age\nat death, sex and Lewy body pathology were used to examine associations of vessel disease with the\nseverity of Alzheimer's disease dementia, and cognitive function, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>No significant relationship was observed between late-life risk factors and Alzheimer\u2019s\ndementia. The severity of arteriosclerosis and presence of global infarcts\/lacunes were related to mild\nAlzheimer\u2019s dementia (B=0.423, p&lt;0.001; B=0.366, p=0.026), and the effects were significant after\nadjusting for neuritic plaques and neurofibrillary tangles (B=0.385, p&lt;0.001; B=0.63, p=0.001). When\nvascular brain injuries were subdivided into old and acute\/subacute types, we found that old microinfarcts\nand old microbleeds were associated with mild Alzheimer\u2019s dementia (B=0.754, p=0.007;\nB=2.331, p=0.032). The old microinfarcts remained significantly associated with mild Alzheimer\u2019s\ndementia after correcting AD pathologies (B=1.31, p&lt;0.001). In addition, the number of microinfarcts\nin the cerebral cortex had a significant relation with mild Alzheimer\u2019s dementia, whether or not the\ndata were corrected for AD pathologies (B=0.616, p=0.016; B=0.884, p=0.005). Atherosclerosis, arteriosclerosis\nand white matter rarefaction were found to be significantly associated with faster progression\nof Alzheimer\u2019s dementia (B=0.068, p=0.001; B=0.046, p=0.016, B=0.081, p=0.037), but white\nmatter rarefaction no longer had a significant effect after adjusting for AD pathologies. We also found\nthat the severity of atherosclerosis was related to impairment in processing speed (\u03b2=-0.112, p=0.006)\nand executive function (\u03b2=-0.092, p=0.023). Arteriosclerosis was significantly associated with language\n(\u03b2=-0.103, p=0.011) and global cognition (\u03b2=-0.098, p=0.016) deficits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our study found the significant relation of global, old, acute\/subacute and regional cerebral\nvascular pathologies, but not white matter rarefaction, to the onset and severity of Alzheimer\u2019s\ndementia. We also showed that late-life risk factors were found to have no relation with Alzheimer\u2019s\ndementia, and the increased risk of dementia with APOE \u03b54 is not mediated by CVD. The best interpretation\nof these findings is that CVD has a potential additive effect with AD pathologies in the development\nand progression of what is clinically diagnosed as Alzheimer's dementia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1567205018666210212160902","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T23:51:27Z","timestamp":1613346687000},"page":"1167-1176","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer\u2019s Dementia Using the NACC Database"],"prefix":"10.2174","volume":"17","author":[{"given":"Yue","family":"Liu","sequence":"first","affiliation":[{"name":"Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Aged Care and Rehabilitation, Bankstown Hospital, Bankstown, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Crawford","sequence":"additional","affiliation":[{"name":"Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perminder S.","family":"Sachdev","sequence":"additional","affiliation":[{"name":"Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nady","family":"Braidy","sequence":"additional","affiliation":[{"name":"Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.101002","volume":"58","author":"Azarpazhooh M.R.","year":"2020","unstructured":"Azarpazhooh M.R.; Avan A.; Cipriano L.E.; A third of community-dwelling elderly with intermediate and high level of Alzheimer\u2019s neuropathologic changes are not demented: A meta-analysis. Ageing Res Rev 2020,58","journal-title":"Ageing Res Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","volume":"12","author":"Attems J.","year":"2014","unstructured":"Attems J.; Jellinger K.A.; The overlap between vascular disease and Alzheimer\u2019s disease-lessons from pathology. BMC Med 2014,12,206","journal-title":"BMC Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"Toledo J.B.","year":"2013","unstructured":"Toledo J.B.; Arnold S.E.; Raible K.; Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre. Brain 2013,136(Pt 9),2697-2706","journal-title":"Brain"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00401-018-1928-6","volume":"137","author":"Broce I.J.","year":"2019","unstructured":"Broce I.J.; Tan C.H.; Fan C.C.; Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer\u2019s disease. Acta Neuropathol 2019,137(2),209-226","journal-title":"Acta Neuropathol"},{"key":"ref=5","first-page":"270","volume":"18","author":"Beekly D.L.","year":"2004","unstructured":"Beekly D.L.; Ramos E.M.; van Belle G.; NIA-Alzheimer\u2019s Disease Centers. The National Alzheimer\u2019s Coordinating Center (NACC) Database: An Alzheimer disease database. Alzheimer Dis Assoc Disord 2004,18(4),270-277","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/01.wad.0000213865.09806.92","volume":"20","author":"Morris J.C.","year":"2006","unstructured":"Morris J.C.; Weintraub S.; Chui H.C.; The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006,20(4),210-216","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/NEN.0000000000000016","volume":"72","author":"Serrano-Pozo A.","year":"2013","unstructured":"Serrano-Pozo A.; Qian J.; Monsell S.E.; Frosch M.P.; Betensky R.A.; Hyman B.T.; Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center. J Neuropathol Exp Neurol 2013,72(12),1182-1192","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/WAD.0b013e3181ffa76d","volume":"25","author":"Hayden K.M.","year":"2011","unstructured":"Hayden K.M.; Jones R.N.; Zimmer C.; Factor structure of the National Alzheimer\u2019s Coordinating Centers uniform dataset neuropsychological battery: An evaluation of invariance between and within groups over time. Alzheimer Dis Assoc Disord 2011,25(2),128-137","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1001\/jama.2018.21973","volume":"321","author":"Lee H.","year":"2019","unstructured":"Lee H.; Herbert R.D.; McAuley J.H.; Mediation Analysis. JAMA 2019,321(7),697-698","journal-title":"JAMA"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13195-016-0188-8","volume":"8","author":"Prince M.","year":"2016","unstructured":"Prince M.; Ali G.C.; Guerchet M.; Prina A.M.; Albanese E.; Wu Y.T.; Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther 2016,8(1),23","journal-title":"Alzheimers Res Ther"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Yamazaki Y.","year":"2019","unstructured":"Yamazaki Y.; Zhao N.; Caulfield T.R.; Liu C.C.; Bu G.; Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies. Nat Rev Neurol 2019,15(9),501-518","journal-title":"Nat Rev Neurol"},{"key":"ref=12","first-page":"938","volume":"7","author":"Rohn T.T.","year":"2014","unstructured":"Rohn T.T.; Day R.J.; Sheffield C.B.; Rajic A.J.; Poon W.W.; Apolipoprotein E pathology in vascular dementia. Int J Clin Exp Pathol 2014,7(3),938-947","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jalz.2016.09.007","volume":"13","author":"Corrada M.M.","year":"2017","unstructured":"Corrada M.M.; Hayden K.M.; Paganini-Hill A.; Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study. Alzheimers Dement 2017,13(2),103-110","journal-title":"Alzheimers Dement"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/01.wnl.0000288181.00826.63","volume":"70","author":"Arvanitakis Z.","year":"2008","unstructured":"Arvanitakis Z.; Schneider J.A.; Wilson R.S.; Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 2008,70(19 Pt 2),1795-1802","journal-title":"Neurology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.amjmed.2009.08.015","volume":"123","author":"Zamb\u00f3n D.","year":"2010","unstructured":"Zamb\u00f3n D.; Quintana M.; Mata P.; Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am J Med 2010,123(3),267-274","journal-title":"Am J Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","volume":"62","author":"Thal D.R.","year":"2003","unstructured":"Thal D.R.; Ghebremedhin E.; Orantes M.; Wiestler O.D.; Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 2003,62(12),1287-1301","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1358863X08095027","volume":"14","author":"Rafnsson S.B.","year":"2009","unstructured":"Rafnsson S.B.; Deary I.J.; Fowkes F.G.; Peripheral arterial disease and cognitive function. Vasc Med 2009,14(1),51-61","journal-title":"Vasc Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S1474-4422(16)30029-1","volume":"15","author":"Arvanitakis Z","year":"2016","unstructured":"Arvanitakis Z; Capuano AW; Leurgans SE; Bennett DA; Schneider JA; Relation of cerebral vessel disease to Alzheimer\u2019s disease dementia and cognitive function in elderly people: A cross-sectional study. Lancet Neurol 2016,15(9),934-943","journal-title":"Lancet Neurol"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/191382","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191382\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/191382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T08:33:27Z","timestamp":1640162007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191382\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":18,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,3,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205018666210212160902","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}